Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 4, 2012
Authors not listed
Stanford University · 2012
Abstract
This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2012). Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 4, 2012. <em>Stanford University</em>. https://clinicaltrials.gov/study/NCT03022435
Vancouver
Anonymous. Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 4, 2012. Stanford University. 2012.
BibTeX
@misc{anon2012Protec,
title = {Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 4, 2012},
author = {Anonymous},
journal = {Stanford University},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stanford University 2010
Open access · US-GOV
Protective Mechanisms Against a Pandemic Respiratory Virus: B- Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 2, 2010
Stanford University 2009
Open access · US-GOV
U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 1, 2009
The Jackson Laboratory 2017
Open access · US-GOV
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
GlaxoSmithKline 2007
Open access · US-GOV
An Extension Study to Evaluate the Persistence of the Immune Responses Induced by GSK Biologicals Zoster Vaccine, GSK324332A, Administered in Healthy Adult Subjects Aged 18-30 Years and 50-70 Years
Cells 2019
Open access · CC-BY
Modulation of Autophagy for Controlling Immunity
Nature Communications 2016
Open access · CC-BY